DK76193D0 - CARBOHYDRATE DERIVATIVES - Google Patents

CARBOHYDRATE DERIVATIVES

Info

Publication number
DK76193D0
DK76193D0 DK93761A DK76193A DK76193D0 DK 76193 D0 DK76193 D0 DK 76193D0 DK 93761 A DK93761 A DK 93761A DK 76193 A DK76193 A DK 76193A DK 76193 D0 DK76193 D0 DK 76193D0
Authority
DK
Denmark
Prior art keywords
carbohydrate derivatives
carbohydrate
derivatives
Prior art date
Application number
DK93761A
Other languages
Danish (da)
Inventor
Hans Roland Loenn
Karin Ingeborg Eklind
Anna-Karin Ulla Edit Tiden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to DK93761A priority Critical patent/DK76193D0/en
Publication of DK76193D0 publication Critical patent/DK76193D0/en
Priority to PCT/SE1994/000604 priority patent/WO1995000527A1/en
Priority to JP7502720A priority patent/JPH08512026A/en
Priority to AU70891/94A priority patent/AU7089194A/en
Priority to EP94919945A priority patent/EP0706528A1/en
Priority to CA002164961A priority patent/CA2164961A1/en
Priority to IL11007494A priority patent/IL110074A0/en
Priority to IS4181A priority patent/IS4181A/en
Priority to LTIP1978A priority patent/LT3446B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK93761A 1993-06-25 1993-06-25 CARBOHYDRATE DERIVATIVES DK76193D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DK93761A DK76193D0 (en) 1993-06-25 1993-06-25 CARBOHYDRATE DERIVATIVES
PCT/SE1994/000604 WO1995000527A1 (en) 1993-06-25 1994-06-17 Fucosylated glycosides as inhibitors of bacterial adherence
JP7502720A JPH08512026A (en) 1993-06-25 1994-06-17 Fucosylated glycosides as bacterial adhesion inhibitors
AU70891/94A AU7089194A (en) 1993-06-25 1994-06-17 Fucosylated glycosides as inhibitors of bacterial adherence
EP94919945A EP0706528A1 (en) 1993-06-25 1994-06-17 Fucosylated glycosides as inhibitors of bacterial adherence
CA002164961A CA2164961A1 (en) 1993-06-25 1994-06-17 Fucosylated glycosides as inhibitors of bacterial adherence
IL11007494A IL110074A0 (en) 1993-06-25 1994-06-21 Fucosylated glycosides as inhibitors of bacterial adherence
IS4181A IS4181A (en) 1993-06-25 1994-06-22 Fucosylated glycosides that inhibit the adhesion of bacteria
LTIP1978A LT3446B (en) 1993-06-25 1994-06-27 Fucolsylated glycosides as inhibitor of bacterial adherence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93761A DK76193D0 (en) 1993-06-25 1993-06-25 CARBOHYDRATE DERIVATIVES

Publications (1)

Publication Number Publication Date
DK76193D0 true DK76193D0 (en) 1993-06-25

Family

ID=8097261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93761A DK76193D0 (en) 1993-06-25 1993-06-25 CARBOHYDRATE DERIVATIVES

Country Status (9)

Country Link
EP (1) EP0706528A1 (en)
JP (1) JPH08512026A (en)
AU (1) AU7089194A (en)
CA (1) CA2164961A1 (en)
DK (1) DK76193D0 (en)
IL (1) IL110074A0 (en)
IS (1) IS4181A (en)
LT (1) LT3446B (en)
WO (1) WO1995000527A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
JPH1160590A (en) * 1997-08-22 1999-03-02 Yakult Honsha Co Ltd Oligofucose derivative or oligorhamnose derivative and method for producing the same
SE9901007D0 (en) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
WO2007021721A2 (en) * 2005-08-09 2007-02-22 Glycomimetics, Inc. Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
EP2794626B3 (en) 2011-12-22 2020-08-05 GlycoMimetics, Inc. E-selectin antagonist compounds
EP2692740A1 (en) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Glycan compositions, processes for preparing the same and their uses as a drug
HUE038423T2 (en) 2012-12-07 2018-10-29 Glycomimetics Inc Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
CN105101972A (en) * 2013-01-31 2015-11-25 先锋国际良种公司 Synthetic lipochitooligosaccharides for improvement of plant growth and yield
WO2014210397A1 (en) * 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
CN107108679B (en) 2014-12-03 2020-10-23 糖模拟物有限公司 Heterobifunctional inhibitors of E-selectin and CXCR4 chemokine receptors
WO2017127422A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
BR112019006642A2 (en) 2016-10-07 2019-07-02 Glycomimetics Inc highly potent multimeric e-selectin antagonists
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
EP3717013A1 (en) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
US11548908B2 (en) 2017-12-29 2023-01-10 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
EP3841123A2 (en) 2018-08-23 2021-06-30 Seagen Inc. Anti-tigit antibodies
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
JP7547345B2 (en) 2018-12-27 2024-09-09 グリコミメティクス, インコーポレイテッド Galectin-3 Inhibitory C-Glycosides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1603609A (en) * 1977-04-14 1981-11-25 Chembiomed Ltd O-protected 2-azido-2-deoxy-glycosyl nitrates
FR2509313A1 (en) * 1981-07-08 1983-01-14 Choay Sa 3-FUCOSYL-N-ACETYL LACTOSAMINE DERIVATIVES, THEIR PREPARATION AND THEIR BIOLOGICAL APPLICATIONS
DE3220427A1 (en) * 1982-05-29 1983-12-01 Behringwerke Ag, 3550 Marburg SS-D-GALACTOSE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DK17685D0 (en) * 1985-01-14 1985-01-14 Hans Goeran Magnusson glycoside
EP0348143A3 (en) * 1988-06-21 1991-03-13 MARION LABORATORIES, INC. (a Delaware corporation) Bismuth derivatives of saccharide phosphates and sulphates

Also Published As

Publication number Publication date
IL110074A0 (en) 1994-10-07
CA2164961A1 (en) 1995-01-05
IS4181A (en) 1994-12-26
AU7089194A (en) 1995-01-17
JPH08512026A (en) 1996-12-17
LTIP1978A (en) 1995-01-31
LT3446B (en) 1995-10-25
WO1995000527A1 (en) 1995-01-05
EP0706528A1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
FI943976A7 (en) 5-arylindole derivatives
DK0719278T3 (en) Androstenone derivatives
FI943296A7 (en) Cation-complexed polysaccharides
FI930208L (en) QUINAZOLE DERIVATIVES
FI935431A7 (en) Kianzoline derivatives
FI980341L (en) 2-Oxyindole derivatives
ATA75293A (en) INDOLDER DERIVATIVES
FI933037A7 (en) THIAZOLOLYLPHENYL DERIVATIVES
FI941423A7 (en) 17beta-substituted 4-aza-5alpha-androstan-3-one derivatives
FI921262L (en) 4-ARYLTHIAZOLE OR 4-ARYLIMIDAZOLE DERIVATIVES
FI945674L (en) Substituted 2beta-morpholine-androstane derivatives
DE69330497D1 (en) CHINAZOLIN DERIVATIVES
FI20010214L (en) Acylaminoindole derivatives
FI942444A7 (en) Terahydropyran derivatives
FI943885L (en) Penaam derivatives
DE59308714D1 (en) CYCLOBUTANE-BENZENE DERIVATIVES
FI20002460L (en) 4-diphenylmethylpiperidine derivatives
FI944044L (en) Phenylalkanolamine derivatives
DK0818459T3 (en) Carbohydrate derivatives
FI92525B (en) Ventilation-heating unit
NO952288D0 (en) Benzazepinon derivatives
DE69313890D1 (en) 5-aminoflavone derivatives
MX9206710A (en) PIRIDINOL DERIVATIVES
FI930367L (en) PURIDINE DERIVATIVES
FI924145L (en) 3-CYCLOALKYLPROP-2-ENAMIDER DERIVATIVES

Legal Events

Date Code Title Description
A0 Application filed
AHS Application shelved for other reasons than non-payment